首页> 外国专利> NK NK cell receptor and its use for diagnosis and prognosis of antibody-mediated rejection after kidney transplantation

NK NK cell receptor and its use for diagnosis and prognosis of antibody-mediated rejection after kidney transplantation

机译:NK NK细胞受体及其用于肾移植术后抗体介导的抗体抑制的诊断和预后

摘要

The present invention relates to a NK cell receptor and its use for diagnosing antibody-mediated rejection (ABMR) and predicting the prognosis after kidney transplantation, and it is possible to diagnose or predict transplant rejection after kidney transplantation. However, in particular, it is possible to diagnose antibody-mediated rejection by distinguishing it from T cell-mediated rejection and/or mixed rejection, so that the cause of kidney transplant rejection can be diagnosed more precisely and precisely, and treatment methods can be determined.
机译:本发明涉及NK细胞受体及其用于诊断抗体介导的抑制(ABMR)并预测肾移植后预后的用途,并且可以在肾移植后诊断或预测移植排斥。 然而,特别地,可以通过将其与T细胞介导的抑制和/或混合排斥区别区区诊断抗体介导的排斥反应,从而可以更精确且精确地诊断肾移植排斥的原因,并且可以是治疗方法 决定。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号